You can buy or sell SGEN and other stocks, options, ETFs, and crypto commission-free!
Seattle Genetics, Inc. Common Stock, also called Seattle Genetics, is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Read More Its product Adcetris is an antibody-drug for the treatment of lymphoma. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.
52 Week High
52 Week Low
Expected Oct 15, After Hours